MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 28.16
+0.10 (0.36%)
At close: Nov 28, 2025
MedinCell Market Cap
MedinCell has a market cap or net worth of €931.92 million as of November 28, 2025. Its market cap has increased by 85.37% in one year.
Market Cap
931.92M
Enterprise Value
927.35M
Revenue
27.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€28.16
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 931.92M, an increase of 537.84%. That is a compound annual growth rate of 29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 931.92M | 91.84% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | 225.98M | 63.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.51B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.50B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.45B |
| Virbac | 3.09B |